COSMOS HEALTH NEW DL-01 (F:V67A) — Stock Price
COSMOS HEALTH NEW DL-01 (F:V67A) is currently trading at €0.20 EUR, down 5.28% today. Over the past 52 weeks, shares have ranged between €0.15 and €1.06. This page tracks COSMOS HEALTH NEW DL-01's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see COSMOS HEALTH NEW DL-01 (V67A) market capitalisation.
COSMOS HEALTH NEW DL-01 (V67A) Stock Price Chart — Daily History & Trading Volume
The chart below tracks COSMOS HEALTH NEW DL-01's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
COSMOS HEALTH NEW DL-01 Income Statement — Revenue, Profit & Earnings by Year
COSMOS HEALTH NEW DL-01's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €65.27 Million | €54.43 Million | €53.38 Million | €50.35 Million | €56.24 Million |
| Cost of Revenue | €57.38 Million | €50.12 Million | €49.03 Million | €44.39 Million | €47.91 Million |
| Gross Profit | €7.90 Million | €4.31 Million | €4.35 Million | €5.96 Million | €8.33 Million |
| Research & Development | €519.36K | €533.29K | €164.86K | — | — |
| SG&A | €22.55 Million | €17.78 Million | €25.40 Million | €13.24 Million | €12.41 Million |
| Total Operating Expenses | €81.81 Million | €69.68 Million | €75.21 Million | €57.82 Million | €60.77 Million |
| Operating Income | €-16.54 Million | €-15.25 Million | €-21.83 Million | €-7.47 Million | €-4.53 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €2.62 Million | €1.01 Million | €866.48K | €3.97 Million | €3.58 Million |
| Income Before Tax | €-19.14 Million | €-16.18 Million | €-18.54 Million | €-13.06 Million | €-7.85 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-19.14 Million | €-16.18 Million | €-18.54 Million | €-13.83 Million | €-7.96 Million |
COSMOS HEALTH NEW DL-01 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes COSMOS HEALTH NEW DL-01's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €65.48 Million | €54.31 Million | €66.01 Million | €68.04 Million | €49.43 Million |
| Total Current Assets | €38.39 Million | €25.46 Million | €36.61 Million | €56.37 Million | €39.83 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €46.16K | €21.15K | €20.07K | €14.88K | €11.47K |
| Net Receivables | €19.63 Million | €13.48 Million | €19.76 Million | €23.69 Million | €26.49 Million |
| Inventory | €5.78 Million | €4.36 Million | €4.79 Million | €3.45 Million | €3.15 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €49.70K | €49.70K | €49.70K | €49.70K | €49.70K |
| Total Liabilities | €47.05 Million | €29.78 Million | €29.97 Million | €28.38 Million | €45.05 Million |
| Total Current Liabilities | €38.27 Million | €25.76 Million | €24.32 Million | €21.75 Million | €29.93 Million |
| Long-term Debt | €5.85 Million | €1.56 Million | €3.04 Million | €2.86 Million | €12.72 Million |
| Net Debt | €18.65 Million | €10.80 Million | €7.43 Million | — | €25.78 Million |
| Total Stockholder Equity | €18.42 Million | €24.53 Million | €36.04 Million | €39.66 Million | €4.38 Million |
| Retained Earnings | €-133.17 Million | €-114.02 Million | €-91.64 Million | €-66.23 Million | €-34.35 Million |
COSMOS HEALTH NEW DL-01 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how COSMOS HEALTH NEW DL-01 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-8.45 Million | €-7.72 Million | €-15.64 Million | €-14.87 Million | €-7.10 Million |
| Capital Expenditures | €152.82K | €1.27 Million | €9.17 Million | €383.07K | €890.52K |
| Free Cash Flow | €-8.60 Million | €-8.98 Million | €-24.80 Million | €-15.25 Million | €-7.99 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | €14.06 Million | €5.05 Million | €12.69 Million | €35.05 Million | €7.27 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €2.31 Million | €1.69 Million | €577.93K | €24.40K | €5.90 Million |
| Depreciation | €1.37 Million | €1.25 Million | €614.38K | €188.89K | €449.69K |
| Change in Cash | €3.14 Million | €-3.52 Million | €-16.92 Million | €20.46 Million | €-341.91K |
COSMOS HEALTH NEW DL-01 Earnings History — EPS Actual vs. Analyst Estimates
Track COSMOS HEALTH NEW DL-01's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 13, 2026 | — | — | — |
| Nov 12, 2025 | — | — | — |
| Sep 29, 2025 | — | — | — |
| Apr 16, 2025 | — | — | — |
| Nov 18, 2024 | — | — | — |